Loading data for IART — first visit, this takes a few seconds.
Integra LifeSciences Holdings Corporatio... (IART)
NasdaqGS: IART
· 实时价格 · USD
16.72
+0.28 (1.70%)
收盘价： Sep 04, 2026, 8:00 PM
16.58
-0.84%
盘后: 7:43 PM
股价、关键数字和最新消息，都在这一页。
Integra LifeSciences Holdings Corporation（IART）股价、分析与数据
暂无数据
| 买价 | 11.83 |
| 市值 | 1.3B |
| 营收（TTM） | 1.65B |
| 净利润（TTM） | -7.24M |
| 1.21 | |
| -0.09 | |
| n/a | |
| 6.41 | |
| 市净率（TTM） | 1.25 |
| 市销率（TTM） | 0.79 |
| 财报日期 | Oct 29, 2026 |
| 卖价 | 20.92 |
| 成交量 | 674,913 |
| 20日均量 | 857,277 |
| 开盘价 | 16.32 |
| 前收盘价 | 16.44 |
| 日内区间 | 16.25 - 16.78 |
| 52周区间 | 8.70 - 20.49 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 IART
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management d...
公司完整简介财报意外
Integra LifeSciences s 已于 Jul 29, 2026 发布季度财报：
- 营收为 $418.76M 低于预期 $0, ， 0.76% 同比增长.
- 每股收益为 0.56 超出预期 0.08, ， 24.44% 同比增长.
第 1 页，共 2 页